Paul Gordon, MD

  • Gordon PH, Younger DS. Neurolymphomatosis of the median nerve. Neurology 1996;46:1191.
  • Younger DS, Gordon PH. Diagnosis in neuromuscular diseases. In: Evans RW, ed. Neurologic Clinics. Philadelphia : WB Saunders, 1996;14(1):135-168.
  • Gordon PH, Hays AP, Rowland LP, Dickoff DJ, Schotland DL, Rosenberg RN, Wolfe DE, Lange DJ, Lovelace RE. Erroneous diagnosis corrected after 27 years: Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. Arch Neurol 1996;53:1194-1196.
  • Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED, Lange DJ, Trojaborg W, Lovelace RE, Murhpy PL , Latov N. Lymphoprofiferative disorders and motor neuron disease: An update. Neurology 1997;48:1671-1678.
  • Gordon PH, Brannagan TH, Latov N. Neurological manifestations of paraproteinemia and cryoglobulinemia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. Amsterdam : Elsevier Science Publishers 1998;431-459.
  • Gordon PH, Frucht SJ, Fahn S. Parkinson’s disease: identification, management and new treatment options. Progress in Neurology 2000;2:3-21.
  • Gordon PH, Wilbourn AJ. Early electrodiagostic findings in Guillain-Barre Syndrome. Arch Neruol 2001 58:913-917.
  • Gordon PH, Frucht SJ. Neuroleptic malignant syndrome in advanced parkinson’s disease. Mov Disord 2001;16:960-962.
  • Gordon PH, Pullman SL, Louis ED, Frucht SJ, Fahn S. Mirtazapine in parkinsonian tremor. Parkinsonism Relat Disord 2002;9:125-126.
  • Gordon PH, Gooch CL, Greene PE. The extensor digitorum brevis test and resistance to botulinum toxin type A. Muscle Nerve 2002;26:828-831.
  • Gordon PH, Mitsumoto H, Hays AP. Amyotrophic lateral sclerosis. Sci. SAGE KE 2003; 35: dn2 (DOI:10.1126/sageke.2003.35.dn2).
  • Gordon PH, Moore DH, Gelinas DF, Qualls C, Meister ME, Werner J, Mendoza M, Mass J, Kushner G, Miller RG. Placebo Controlled Phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 2004;62:1845-1847.
  • Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction and movement time after embryonic cell implantation in parkinson’s disease. Arch Neurol   2004;61:858-861.
  • Gordon PH, Fahn S, Chin S, Eidelberg, Golbe LI, Lynch, T. What is it: a woman with a twenty-six year history of parkinsonism and supranuclear ophthalmoplegia. Mov Disord 2004;19:950-961.
  • Gordon PH, Miller RG, Moore DH. ALSFRS-R as a primary outcome measure in ALS clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5(Suppl 1):90-93.
  • Gordon PH. Advances in clinical trials of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2005. In Press.
  • Mitsumoto H, Gordon PH, Kaufmann P, Gooch C, Przedborski S, Rowland LP. Randomized control trials in ALS: lessons learned. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(suppl 1): 8-13.
  • Rowland LP, Gordon PH. Hereditary and Acquired Spastic Paraplegia. In: LP Rowland, ed. Merritt’s Textbook of Neurology 11 th edition. Philadelphia : Lippincott Williams & Wilkins. 2004. In Press.
  • Rowland LP, Gordon PH. Familial Periodic Paralysis. In: LP Rowland, ed. Merritt’s Textbook of Neurology 11 th edition. Philadelphia : Lippincott Williams & Wilkins. 2004. In Press.

Abstracts

  • Gordon PH, Rowland LP, Louis Ed, Sherman WH, Hays AP, Lange DJ, Trojaborg W, Lovelace RE, Murphy PL , Latov N. Lymphoproliferative disorders and motor neuron disease. Ann Neurol (abstract) 1996;40:544.
  • Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre Syndrome. Neurology 2000 (Suppl 3);54:A46.
  • Pullman SL, Gordon PH, Fahn S, Yu Q. Computerized analysis of reaction and movement times after fetal cell tissue transplantation in parkinson disease patients. Neurology 2000 (Suppl 3);54:A49.
  • Gordon PH, Pullman SL, Louis ED, Frucht SJ, Fahn S. Mirtazapine in parkinsonian tremor and essential tremor. Neurology 2001 (Suppl 3);56:A25
  • Gordon PH, Gooch CL, Greene PE. The extensor digitorum brevis test and immunoresistance to botulinum toxin type A. Muscle Nerve (abstract) 2000;24:1434.
  • Gordon PH. Minocycline in amyotrophic lateral sclerosis (abstract). ALS and Other Motor Neuron Disorders 2001;2(suppl 2):161-162.
  • Reider CR, Halter CA , Foroud T, Oakes D, and the Parkinson Study Group. Reliability of self-reporting age of onset for Parkinsons’s disease. Mov Disord (abstract) 2001;16:991.
  • Gordon PH, Miller RG, Moore DH, Gelinas DF, Meister ME, Werner J, Mendoza M, Mass J, Kushner G. Placebo controlled phase II studies of minocycline in amyotrophic lateral sclerosis. Neurology (abstract) 2003.
  • Florence JM, Moore DH, Mendoza M, Mass J, Renna R, Malinowski L, Parnell J, Roelke K, Gelinas D, Brooks B, Gordon PH, Miller RG. Validation of telephonic administration of the ALSFRS-R. Neurology 2004;62 (Suppl 5):A134.
  • Mitsumoto H, Shungu DC, Ulug A, Pulman SL, Gooch C, Chan S, Tang MX, Xiangling M, Dashnaw S, Gaspard G, Garcia J, Del Bene M, Battista V, Gad N, Montes J, Hays S, Albert S, Hirsch J, Hays AP, Kaufmann P, Gordon PH, Beal MF, Rowland LP. Obejctive upper motor neuron and lower motor neuron markers of amyotrophic lateral sclerosis. Neurology 2004;62(supl 5):A278.
  • Gordon PH, Pinto M, Mitsumoto H, Kaufmann P, Rowland LP. The clinical manifestations of primary lateral sclerosis. ALS and Other Motor Neuron Disorders 2004;5(suppl 2):112.
  • Rippon GA, Goldstein S, Murphy PL, Gordon PH, Del Bene M, Scarmeas N, Albert SM, Mitsumoto H, Marker K, Rowland LP, Stern Y. A pilot study of cognitive impairment in ALS. ALS and Other Motor Neu